These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38795644)

  • 1. New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome.
    Zhao J; Duan L; Li J; Yao C; Wang G; Mi J; Yu Y; Ding L; Zhao Y; Yan G; Li J; Zhao Z; Wang X; Li M
    Biomed Pharmacother; 2024 Jul; 176():116807. PubMed ID: 38795644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiome and metabolic syndrome.
    Dabke K; Hendrick G; Devkota S
    J Clin Invest; 2019 Oct; 129(10):4050-4057. PubMed ID: 31573550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
    Larabi A; Barnich N; Nguyen HTT
    Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and metabolic syndrome.
    Wang PX; Deng XR; Zhang CH; Yuan HJ
    Chin Med J (Engl); 2020 Apr; 133(7):808-816. PubMed ID: 32106124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
    Yang S; Hu T; Liu H; Lv YL; Zhang W; Li H; Xuan L; Gong LL; Liu LH
    Biomed Pharmacother; 2021 Jun; 138():111441. PubMed ID: 33652261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatically synthesized α-galactooligosaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with the modulation of gut microbiota.
    He N; Chen H; Zhou Z; Zhao W; Wang S; Lv Z; Liu N; Wang H; Yang Z; Li S
    Food Funct; 2021 Jun; 12(11):4960-4971. PubMed ID: 34100482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.
    Hao Y; Zhu YJ; Zou S; Zhou P; Hu YW; Zhao QX; Gu LN; Zhang HZ; Wang Z; Li J
    Front Immunol; 2021; 12():711060. PubMed ID: 34367173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Profiles of Treated Metabolic Syndrome Patients and their Relationship with Metabolic Health.
    Wutthi-In M; Cheevadhanarak S; Yasom S; Kerdphoo S; Thiennimitr P; Phrommintikul A; Chattipakorn N; Kittichotirat W; Chattipakorn S
    Sci Rep; 2020 Jun; 10(1):10085. PubMed ID: 32572149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial.
    Chen Y; Feng R; Yang X; Dai J; Huang M; Ji X; Li Y; Okekunle AP; Gao G; Onwuka JU; Pang X; Wang C; Li C; Li Y; Sun C
    Am J Clin Nutr; 2019 Jun; 109(6):1611-1619. PubMed ID: 31136662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota.
    Luo Z; Xu W; Zhang Y; Di L; Shan J
    Pharmacol Res; 2020 Oct; 160():105088. PubMed ID: 32683035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome.
    de Cossío LF; Fourrier C; Sauvant J; Everard A; Capuron L; Cani PD; Layé S; Castanon N
    Brain Behav Immun; 2017 Aug; 64():33-49. PubMed ID: 28027925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional Approaches Targeting Gut Microbiota in Oxidative-Stress-Associated Metabolic Syndrome: Focus on Early Life Programming.
    Tain YL; Hsu CN
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.
    Xiao S; Zhao L
    FEMS Microbiol Ecol; 2014 Feb; 87(2):303-14. PubMed ID: 24219358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
    Koopen AM; de Clercq NC; Warmbrunn MV; Herrema H; Davids M; de Groot PF; Kootte RS; Bouter KEC; Nieuwdorp M; Groen AK; Prodan A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32752028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbes: possible link between modern lifestyle transition and the rise of metabolic syndrome.
    Moossavi S; Bishehsari F
    Obes Rev; 2019 Mar; 20(3):407-419. PubMed ID: 30548384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.
    Verdugo-Meza A; Ye J; Dadlani H; Ghosh S; Gibson DL
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Influences on Gut Microbiota with a Focus on Metabolic Syndrome.
    Thomas MS; Blesso CN; Calle MC; Chun OK; Puglisi M; Fernandez ML
    Metab Syndr Relat Disord; 2022 Oct; 20(8):429-439. PubMed ID: 35704900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Mediterranean Diet on plasma metabolites and their relationship with insulin resistance and gut microbiota composition in a crossover randomized clinical trial.
    Galié S; García-Gavilán J; Papandreou C; Camacho-Barcía L; Arcelin P; Palau-Galindo A; Rabassa A; Bulló M
    Clin Nutr; 2021 Jun; 40(6):3798-3806. PubMed ID: 34130026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.